Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics
Oncology Research · 2026 · 34 (1) · 1-10
DOI: 10.32604/or.2025.069049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Shujie Yin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, 31…. Hauptthemen laut MEDLINE: Ferroptosis, Cuproptosis, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biopharmaceutics, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Zitieren
APA
Yin, S., Li, Z., & Ou, W. B. (2026). Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics. Oncology Research, 34(1), 1-10. https://doi.org/10.32604/or.2025.069049
Vancouver
Yin S, Li Z, Ou WB. Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics. Oncology Research. 2026;34(1):1-10. doi:10.32604/or.2025.069049
BibTeX
@article{Yin2026,
author = {Yin, Shujie and Li, Zong and Ou, Wen-Bin},
title = {Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {1},
pages = {1--10},
doi = {10.32604/or.2025.069049}
}
EUVIMED